Regulatorische Updates
Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit
#Mometasone Furoate ×
Regulatorische Updates
15. Sept. 2026•3 Min. Lesezeit
FDA Grants ANDA Approval for Mometasone Furoate Topical Lotion (ANDA077678)
The FDA approved an ANDA (ANDA077678) for a 0.1% mometasone furoate topical lotion submitted by Cosette Pharms NC; the product is listed as discontinued.
Regulatorische Updates
15. Sept. 2026•3 Min. Lesezeit
FDA Approves Sun Pharma Canada ANDA for Mometasone Furoate Topical Lotion
FDA approved ANDA076788 for a Mometasone Furoate 0.1% topical lotion by Sun Pharma Canada; the product is listed as discontinued, with labeling supplements approved in 2015 and 2019.
Regulatorische Updates
15. Sept. 2026•3 Min. Lesezeit
Glenmark Pharm's Mometasone Furoate Ointment (ANDA078571) Receives Multiple Labeling Approvals
The FDA approved the original ANDA for Glenmark's Mometasone Furoate topical ointment on May 28, 2008, and later granted labeling supplements in 2015 and 2024; the product is now discontinued.